Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tube Tug-of-War: keeping or removing drain during pancreatic surgery may cut complications

NCT ID NCT07532759

Knowledge-focused Sponsor: Xu'an Wang Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 16, 2026 · Updated 3 times

Summary

This trial looks at whether keeping or removing a drainage tube (PTCD catheter) during pancreatic surgery leads to fewer complications. About 100 patients with jaundice from tumors will be randomly assigned to one of two groups. The main goal is to see which approach reduces serious problems like bile leaks and other major complications within 90 days after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
PTCD catheter (a drainage tube placed before surgery to relieve bile blockage)
What this could lead to
If this trial succeeds, it could guide surgeons on whether to keep or remove the PTCD tube during pancreatic surgery, potentially reducing serious complications like bile leaks.
What could go wrong
This is an early exploratory trial with only 100 participants, so results may not apply to all patients. The study compares two surgical approaches, not a new drug, so the impact is limited to surgical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Apr 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 to 85 years * Patients with pancreatic head or periampullary tumors scheduled for pancreaticoduodenectomy * Presence of obstructive jaundice and completion of preoperative * percutaneous transhepatic cholangial drainage (PTCD) * Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 * American Society of Anesthesiologists (ASA) physical status ≤ II * Able to understand the study and provide written informed consent Exclusion Criteria: * Presence of distant metastasis or locally unresectable disease * Severe cardiac, renal, or pulmonary dysfunction that contraindicates surgery * Uncontrolled infection * Pregnancy or breastfeeding * History of major surgery within 4 weeks prior to enrollment * Poor compliance or inability to complete follow-up

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Biliary tract neoplasms are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

biliary tract neoplasm Biliary Tract Neoplasms exocrine pancreatic carcinoma obstructive jaundice periampullary adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Biliary tract neoplasms Obstructive jaundice Pancreatic head cancer Periampullary neoplasms

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.